hey guys
I have become aware of $GMAB (-1,08 %) became attentive
looks brutally undervalued
fundamentally great sales profits are rising etc.
there are only supposed to have been complaints from japan and abbvie
but shouldn't that be priced in?
how do you currently see the value
VG THANKS
